176 related articles for article (PubMed ID: 21533273)
1. Efficacious and safe tissue-selective controlled gene therapy approaches for the cornea.
Mohan RR; Sinha S; Tandon A; Gupta R; Tovey JC; Sharma A
PLoS One; 2011 Apr; 6(4):e18771. PubMed ID: 21533273
[TBL] [Abstract][Full Text] [Related]
2. Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy.
Mohan RR; Tandon A; Sharma A; Cowden JW; Tovey JC
Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4833-41. PubMed ID: 21551414
[TBL] [Abstract][Full Text] [Related]
3. Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo.
Mohan RR; Tovey JC; Sharma A; Schultz GS; Cowden JW; Tandon A
PLoS One; 2011; 6(10):e26432. PubMed ID: 22039486
[TBL] [Abstract][Full Text] [Related]
4. Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo.
Mohan RR; Gupta S; Kumar R; Sinha NR; Landreneau J; Sinha PR; Tandon A; Chaurasia SS; Hesemann NP
Ocul Surf; 2024 Apr; 32():13-25. PubMed ID: 38191093
[TBL] [Abstract][Full Text] [Related]
5. Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy.
Liu J; Saghizadeh M; Tuli SS; Kramerov AA; Lewin AS; Bloom DC; Hauswirth WW; Castro MG; Schultz GS; Ljubimov AV
Mol Vis; 2008; 14():2087-96. PubMed ID: 19023450
[TBL] [Abstract][Full Text] [Related]
6. Six-Month In Vivo Safety Profiling of Topical Ocular AAV5-Decorin Gene Transfer.
Mohan RR; Balne PK; Muayad MS; Tripathi R; Sinha NR; Gupta S; An JA; Sinha PR; Hesemann NP
Transl Vis Sci Technol; 2021 Aug; 10(10):5. PubMed ID: 34383877
[TBL] [Abstract][Full Text] [Related]
7. Vector delivery technique affects gene transfer in the cornea in vivo.
Mohan RR; Sharma A; Cebulko TC; Tandon A
Mol Vis; 2010 Nov; 16():2494-501. PubMed ID: 21139995
[TBL] [Abstract][Full Text] [Related]
8. BMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivo.
Tandon A; Sharma A; Rodier JT; Klibanov AM; Rieger FG; Mohan RR
PLoS One; 2013; 8(6):e66434. PubMed ID: 23799103
[TBL] [Abstract][Full Text] [Related]
9. Localization of angiotensin converting enzyme in rabbit cornea and its role in controlling corneal angiogenesis in vivo.
Sharma A; Bettis DI; Cowden JW; Mohan RR
Mol Vis; 2010 Apr; 16():720-8. PubMed ID: 20431722
[TBL] [Abstract][Full Text] [Related]
10. Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo.
Gupta S; Fink MK; Kempuraj D; Sinha NR; Martin LM; Keele LM; Sinha PR; Giuliano EA; Hesemann NP; Raikwar SP; Chaurasia SS; Mohan RR
Mol Ther; 2022 Oct; 30(10):3257-3269. PubMed ID: 35780298
[TBL] [Abstract][Full Text] [Related]
11. Efficient Transduction of Corneal Stroma by Adeno-Associated Viral Serotype Vectors for Implications in Gene Therapy of Corneal Diseases.
Lu Y; Ai J; Gessler D; Su Q; Tran K; Zheng Q; Xu X; Gao G
Hum Gene Ther; 2016 Aug; 27(8):598-608. PubMed ID: 27001051
[TBL] [Abstract][Full Text] [Related]
12. Gene delivery in the equine cornea: a novel therapeutic strategy.
Buss DG; Giuliano E; Sharma A; Mohan RR
Vet Ophthalmol; 2010 Sep; 13(5):301-6. PubMed ID: 20840107
[TBL] [Abstract][Full Text] [Related]
13. Canine corneal fibroblast and myofibroblast transduction with AAV5.
Bosiack AP; Giuliano EA; Gupta R; Mohan RR
Vet Ophthalmol; 2012 Sep; 15(5):291-8. PubMed ID: 22151250
[TBL] [Abstract][Full Text] [Related]
14. Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo.
Gupta S; Rodier JT; Sharma A; Giuliano EA; Sinha PR; Hesemann NP; Ghosh A; Mohan RR
PLoS One; 2017; 12(3):e0172928. PubMed ID: 28339457
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access.
Mohan RR; Schultz GS; Hong JW; Mohan RR; Wilson SE
Exp Eye Res; 2003 Mar; 76(3):373-83. PubMed ID: 12573666
[TBL] [Abstract][Full Text] [Related]
16. Vorinostat: a potent agent to prevent and treat laser-induced corneal haze.
Tandon A; Tovey JC; Waggoner MR; Sharma A; Cowden JW; Gibson DJ; Liu Y; Schultz GS; Mohan RR
J Refract Surg; 2012 Apr; 28(4):285-90. PubMed ID: 22386369
[TBL] [Abstract][Full Text] [Related]
17. Real-time confocal microscopic observations on human corneal nerves and wound healing after excimer laser photorefractive keratectomy.
Linna T; Tervo T
Curr Eye Res; 1997 Jul; 16(7):640-9. PubMed ID: 9222080
[TBL] [Abstract][Full Text] [Related]
18. Detection of corneal fibrosis by imaging second harmonic-generated signals in rabbit corneas treated with mitomycin C after excimer laser surface ablation.
Farid M; Morishige N; Lam L; Wahlert A; Steinert RF; Jester JV
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4377-83. PubMed ID: 18502995
[TBL] [Abstract][Full Text] [Related]
19. [Confocal microscopy of the corneal after photorefractive keratectomy with the excimer laser].
Böhnke M; Schipper I; Thaer A
Klin Monbl Augenheilkd; 1997 Sep; 211(3):159-67. PubMed ID: 9445896
[TBL] [Abstract][Full Text] [Related]
20. Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice.
Kure T; Chang JH; Kato T; Hernández-Quintela E; Ye H; Lu PC; Matrisian LM; Gatinel D; Shapiro S; Gosheh F; Azar DT
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):137-44. PubMed ID: 12506066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
